Scientific Summary - Evidence-Based Gum Therapy
Gum disease and peri-implantitis are common inflammatory conditions in dentistry that can lead to tooth and implant loss. Traditional therapies like scaling and root planing may not always be effective in stopping inflammation and promoting tissue regeneration. Horch (2018) introduces a new approach using active oxygen technology: OXYSAFE® by Ardoz Healthcare International.
Oxysafe-DentalTribuneNL-0218-S2…
How Active Oxygen Works
OXYSAFE® utilizes a patented active oxygen method that targets bacteria within the biofilm, effectively neutralizing anaerobic pathogens deep in gum and peri-implant pockets. Unlike chlorhexidine and antibiotics, this technology can penetrate the biofilm without disrupting the natural oral flora or causing resistance.
Clinical Benefits and Research
Studies show significant reduction in pocket depth, inflammation, and improved gum health with OXYSAFE®. Research from Radboud University Nijmegen reveals a 56% decrease in pathogenic bacteria and partial bone reintegration in 75% of peri-implantitis cases. The treatment also showed positive results in diabetic patients with chronic wounds.
Biocompatibility and Safety
OXYSAFE® is biocompatible and safe, making it suitable for both initial and maintenance phases of gum and implant therapy. It does not harm essential blood cells, mucosal cells, or bone cells.
Dual Treatment Approach
The treatment involves professional application of OXYSAFE® Perio Protection Gel by the dentist, followed by at-home use of OXYSAFE® Liquid Mouthwash. This combination ensures long-term gum stability and reduces the risk of reinfection.
Relevance in Modern Dentistry
OXYSAFE® aligns with the demand for evidence-based, minimally invasive, and antibiotic-sparing approaches in periodontics and implantology. It offers dental professionals a safe and effective alternative for patients.
For more information on innovative dental solutions, visit Ardoz.com for advanced materials and technology supporting superior oral care.